Cargando…
A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators
In this article we analyse the current authorised treatments and trends in early drug development for cystic fibrosis (CF) in the European Union for the time period 2000–2016. The analysis indicates a significant improvement in the innovation and development of new potential medicines for CF, shifti...
Autores principales: | Ponzano, Stefano, Nigrelli, Giulia, Fregonese, Laura, Eichler, Irmgard, Bertozzi, Fabio, Bandiera, Tiziano, Galietta, Luis J.V., Papaluca, Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488862/ https://www.ncbi.nlm.nih.gov/pubmed/29653946 http://dx.doi.org/10.1183/16000617.0124-2017 |
Ejemplares similares
-
Cystic pancreatic lesions, the endless dilemma
por: Okasha, Hussein Hassan, et al.
Publicado: (2021) -
Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes
por: Ma, Oscar Ka-Fai, et al.
Publicado: (2016) -
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
por: Ahumada, Adriana, et al.
Publicado: (2021) -
To ventricular assist devices or not: When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?
por: Cerier, Emily, et al.
Publicado: (2016) -
MicroRNA biomarkers predicting risk, initiation and progression of colorectal cancer
por: Lee, Kyungjin, et al.
Publicado: (2016)